Vincerx Pharma, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OTC.Pink
Vincerx Pharma, Inc. has entered into a non-binding letter of intent with Global Digital Holdings Inc. (QumulusAI) for a proposed business combination via a reverse triangular merger.
OTC.Pink
Tom Thomas, General Counsel and Chief Legal Officer of Vincerx Pharma, reports the repricing of certain stock options approved by stockholders on August 12, 2024.
OTC.Pink
CEO Ahmed Hamdy reports adjustments to stock option holdings in Vincerx Pharma, including repricing of existing options.
OTC.Pink
Alexander Seelenberger, CFO of Vincerx Pharma, reports the repricing of certain stock options approved by stockholders on August 12, 2024.
OTC.Pink
Raquel E. Izumi, a Vincerx Pharma officer, reported the repricing of certain stock options approved by stockholders on August 12, 2024.
OTC.Pink
Alexander A. Seelenberger, CFO of Vincerx Pharma, reports the acquisition of stock options.
OTC.Pink
Raquel E. Izumi, President and Chief Operations Officer of Vincerx Pharma, Inc., reports the acquisition of stock options.
OTC.Pink
Tom C. Thomas, General Counsel and Chief Legal Officer of Vincerx Pharma, Inc., reports the acquisition of stock options.
OTC.Pink
Vincerx Pharma's CEO, Ahmed Hamdy, reports the acquisition of stock options following stockholder approval of an amendment to the company's stock incentive plan.
OTC.Pink
Director Brian Druker reports acquisition of 15,000 stock options in Vincerx Pharma, Inc.
OTC.Pink
Director Francisco D. Salva of Vincerx Pharma, Inc. reports acquiring stock options in a recent transaction.
OTC.Pink
Director John H. Lee acquired 15,000 stock options in Vincerx Pharma, Inc. on May 23, 2024.
OTC.Pink
Director Ruth E. Stevens acquired 15,000 stock options in Vincerx Pharma, Inc. on May 23, 2024.
OTC.Pink
Director Laura I. Bushnell acquired 15,000 stock options in Vincerx Pharma, Inc. on May 23, 2024.
OTC.Pink
Raquel E. Izumi, President and Chief Operations Officer of Vincerx Pharma, acquired stock options for 123,750 shares on March 7, 2024.
OTC.Pink
Alexander Seelenberger, CFO of Vincerx Pharma, reports the acquisition of stock options.
OTC.Pink
Vincerx Pharma's CEO, Ahmed Hamdy, acquired stock options for 146,746 shares on March 7, 2024.
OTC.Pink
Tom C. Thomas, General Counsel and Chief Legal Officer of Vincerx Pharma, Inc., acquired stock options on March 7, 2024.